Volume: 12 Issue: 1
Year: 2024, Page: 3-11, Doi: https://doi.org/10.47799/pimr.1201.02
Received: Jan. 15, 2024 Accepted: March 2, 2024 Published: April 20, 2024
Lupus Anticoagulant (LAC) is a group of auto antiantibodies that interfere with phospholipid dependent tests like Activated Partial Thromboplastin time (APTT) and dilute Russell Viper venom time (dRVVT) on in vitro basis. LA, anti cardiolipin antibodies (aCL) IgG/IgM, and anti-β2 glycoprotein I antibodies [aβ2GPI]IgG/IgM are three diagnostic criteria for laboratory diagnosis of anti-phospholipid antibodies (aPL). The circulating aPLs in the clinical setting of hypercoagulability state or adverse pregnancy outcomes is termed as anti-phospholipid syndrome (APS).
The laboratory diagnosis of APS is complicated, it includes constellation of tests like solid phase immunoassays for measurement of aCL and a β 2GPI by and coagulation based assays for detection of LAC. LAC diagnosis is especially challenging in the setting of anti-coagulation therapy, numerous modifications to circumvent this interference have rendered success.
The Thrombin generation assays [TGA] for LAC detection and estimation of LAC pathogenicity are available but are yet to be accepted as routine laboratory tests. The medley of assays like Enzyme-linked immunosorbent and chemiluminescent assays are available for detection of aCL and aβ2GPI but due to the non-availability of universal calibrators and standards there is lack of harmonization between various solid phase assays.
In this article we intend to highlight new recommendations of laboratory diagnosis of LAC with special emphasis on diagnosis in the setting of pregnancy and anti-coagulation. For risk assessment in APS other non-criteria aPL like as anti-domain β2 glycoprotein I and anti-phosphatidyl serine/prothrombin antibodies are under evaluation.
There is an ongoing quest towards harmonization of detection of LAC, thus there has been succession of guidelines to meet the challenges and incorporate newly found knowledge every time, namely International Society for Thrombosis and Hematology- Scientific Standardization Committee (ISTH-SSC) guidelines, followed by British Committee for Standards in Hematology (BCSH), Clinical and Laboratory Standards Institute (CLSI) guidelines 2014 and finally guidelines/updates issued by ISTH- SSC in 2018.
Keywords: LAC, Autoantibodies, Immunity, Immunoglobulins, Antibodies
Trivedi, S, Jain, P, Mano, A, Singhal, U & Dixit, N . 2022. Lupus anticoagulant: a clinical and laboratory diagnostic dilemma. J Pathol Nep 12(1):1950–1954.
Vandevelde, A & Devreese, KMJ . 2022. Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances. J. Clin. Med 11(8).
Tripodi, A . 2021. Diagnostic Challenges on the Laboratory Detection of Lupus Anticoagulant. Biomedicines 9(7).
Dahlbäck, B, Nilsson, I M & Frohm, B . 1983. Inhibition of platelet prothrombinase activity by a lupus anticoagulant. Blood 62(1):218–225.
Fujieda, Y & Atsumi, T . 2019. Has lupus anticoagulant testing had its day? Nat Rev Rheumatol 15:324–325.
Bowles, L, Platton, S, Yartey, N, Dave M, Daniel, Kurtis L, Macdonald, H, Green, V, Sivapalaratnam, L, Pasi, S, Maccallum, K J, Lupus, P & A . Anti coagulant and abnormal coagulation in Covid-19. N Engl J Med anticoagulant and Abnormal Coagulation Tests in Patients with Covid .
Gebhart, J, Posch, F, Koder, S, Perkmann, T, Quehenberger, P, Zoghlami, C, Ay, C & Pabinger, I . 2015. Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study. Blood 28(125(22)):3477–3483.
Gebhart, J, Posch, F, Koder, S, Quehenberger, P, Perkmann, T, Kuessel, L, Ay, C & Pabinger, I . 2019. High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant. Blood Adv. 3(5):769–776.
Schouwers, S M, Delanghe, J R & Devreese, Kmj . 2010. Lupus Anticoagulant testing in patients with inflammatory status: Does C-reactive protein interfere with LAC test results? Thromb. Res 125:102–104.
Devreese, Kmj, De Groot, P G, De Laat, B, Erkan, D, Favaloro Ej; Mackie, I, Martinuzzo, M, Ortel Tl; Pengo, V & Rand, J H . Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodiesof the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection andinterpretation. J. Thromb. Haemost 2020:2828–2839.
Petri, M . 2019. Improvements in diagnosis and risk assessment of primary and secondary antiphospholipid syndrome. Hematol Educat Progr (1) 415–420.
Yelnik, C M, Porter, T F & Branch, D W . 2016. Brief report: changes in antiphospholipid antibody titers during pregnancy: effects on pregnancy outcomes. Arthrit Rheumatol 68(8):1964–1969.
Balushi, Al, Hasson, M S, Said, S S & E A . 2014. Fluctuation in the levels of immunoglobulin M and immunoglobulin G antibodies for cardiolipin and beta2-glycoprotein among healthy pregnant women. SultanQaboos Univ Med J 14:478–485.
Hellgren, M . 2003. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29(2):125–130.
Devreese, Kmj . 2008. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants. Thromb. Res 123:404–411.
Pengo V; Tripodi, A, Reber, G, Rand, J H, Ortel, T L, Galli, M & De Groot, P G . 2009. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis 7:1737–1740.
Moore, G W, Culhane, A P, Maloney, J C, Archer, R A, Breen, Ka; & Hunt, B J . 2016. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients. Blood Coagul. Fibrinolysis 27:477–480.
Moore, Gw; Jones, Po; Platton, S, Hussain, N, White, D, Thomas, W, Rigano, J, Pouplard C; Gray, E & Devreese, Kmj . 2021. International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. J. Thromb. Haemost 19:3177–3192.
Tripodi, A, Cohen, H & Devreese, Kmj . 2020. Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. J. Thromb. Haemost 18:1569–1575.
Devreese, K, Peerlinck, K, Arnout, J & Hoylaerts, M F . 2009. Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography. Thromb. Haemost 101:185–196.
Devreese, K, Peerlinck, K & Hoylaerts, M F . 2010. Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood 115:870–878.
De Laat-Kremers, Rmw, Wahl, D, Zuily, S, Ninivaggi, M, Chayoua W; Regnault, V, Musial, J, De Groot, P G, Devreese, Kmj & De Laat, B . 2021. Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence. Thromb. Res 203:142–151.
Ninivaggi, M, De Laat-Kremers, Rmw & Tripodi, A . 2021. Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. J Thromb Haemost 19:1372–1378.
Depasse, F, Binder, N B, Mueller, J, Wissel, T, Schwers, S, Germer, M, Hermes, B & Turecek, P L . 2021. Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine. J Thromb Haemost 19(12):2907–2917.
Favaloro, E J, Mohammed, S, Curnow, J & Pasalic, L . 2019. Laboratory testing for lupus anticoagulant [LA] in patients taking direct oral anticoagulants [DOACs]: potential for false positives and false negatives. Pathology 51:30665674.
Frans, G, Meeus, P & Bailleul, E . 2019. Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon. J. Thromb. Haemost. JTH 17:1354–1362.
Kesel, P M De & Devreese, Kmj . 2020. Direct oral anticoagulant adsorption: Impact on lupus anticoagulant testing-Review of the literature and evaluation on spiked and patient samples. J. Thromb. Haemost. 18:2003–2017.
Tripodi, A, Scalambrino, E, Chantarangkul, V, Paoletti, O, Clerici, M, Novembrino, C, Boscolo-Anzoletti, M, Peyvandi, F & Testa, S . 2021. Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection. Thromb. Res 204:32–39.
Zabczyk, M, Kopytek, M, Natorska, J & Undas, A . 2019. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants. Clin. Chem. Lab. Med 57:1374–1381.
Farkh, C, Ellouze, S, Gounelle, L, Houari, M Sad, Duchemin, J, Proulle, V, Fontenay, M, Delavenne, X & Jourdi, G A . 2021. Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter. Front.Med 8:683357.
Sevenet, P O, Cucini, V;, Herve T; Depasse, F;, Carlo, A, Contant, G & Mathieu, O . 2020. Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples. Int. J. Lab. Hematol 42:636–642.
Linskens, E A, De Kesel, P M & Devreese, Kmj . DOAC removal by a DOAC filter: Impact on Lupus Anticoagulant Testing-Evaluation on Spiked and Patient Samples. Res. Pract. Thromb. Haemost 2022:12633.
Moore, Gw; Jones, Po; Platton, S, Hussain, N, White, D, Thomas W; Rigano, J, Pouplard, C & Gray E; Devreese, Kmj . 2021. International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. J. Thromb. Haemost 19:3177–3192.
White, D, Moore, G W, Besser, M, Macdonald, S; & Thomas, W . 2022. Direct oral anticoagulants-Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitors. Res. Pract. Thromb. Haemost. 6:e12648.
©2024 (Shalini Trivedi) et al. This is an open-access journal, and arƟcles are distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
Trivedi S, Verma S, Kaur O, Agarwal S, Singhal U, Singh MB. Antiphospholipid Syndrome and Lupus Anticoagulant: Where do we stand today ?. Perspectives in Medical Research. 2024;12(1):3-11 DOI: 10.47799/pimr.1201.02